MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


WINNERS & LOSERS: Asos sells Lichfield centre; CelLBxHealth revenue up

ALN

The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday.

----------

Main Market small-cap winners

----------

Kendrick Resources PLC, up 39% at 5.20 pence, completes Teufelskuppe rare earth project survey

Wildcat Gold PLC, up 21% at 0.12p

Alternative Liquidity Fund Ltd, up 19% at $0.032

Asos PLC, up 14% at 247.00p, sells Lichfield fulfilment site to M&S for £66 million

London BTC Co Ltd, up 13% at 2.40p

----------

Main Market small-cap losers

----------

Altona Rare Earths PLC, down 13% at 2.80p

Zenith Energy Ltd, down 12% at 5.75p

Macau Property Opportunities Fund Ltd, down 11% at 5.30p

First Class Metals PLC, down 8.3% at 1.65p

Cindrigo Holdings Ltd, down 7.8% at 6.00p

----------

AIM winners

----------

Nativo Resources PLC, up 37% at 0.43 pence, notes gold increase at Tesoro

Novacyt SA, up 36% at 63.60p

Proteome Sciences PLC, up 29% at 1.80p

UKrproduct Group Ltd, up 25% at 7.78p

CelLBxHealth PLC, up 20% at 1.23p, expects higher revenue for 2026

----------

AIM losers

----------

Pacific Global Holdings PLC, down 17% at 1.20p

Galantas Gold Corp, down 8.7% at 31.50p, to raise $85 million in private placement of 154.5 million units at $0.55 each

Allergy Therapeutics PLC, down 7.8% at 10.00p

Cleantech Lithium PLC, down 6.3% at 7.50p

Shoe Zone PLC, down 5.6% at 42.50p, widens interim loss

----------

Small-cap and AIM movers in focus:

----------

Kendrick Resources PLC, up 39% at 5.20 pence, 12-month range 0.15p-5.3p. Completes a digital elevation model survey at its Teufelskuppe rare earth project. The mineral exploration company says the survey identified around 14 million tonnes of high-grade, above-ground carbonatite mineralisation. Adds the visually identifiable mineralisation significantly reduces geological risk at the project.

----------

Asos PLC, up 14% at 247.00 pence, 12-month range 206.50p-375.30p. Sells its Lichfield fulfilment centre to Marks & Spencer for £66 million as part of efforts to simplify operations and strengthen its balance sheet. The online fashion retailer says the disposal will generate annual savings of £6 million and is expected to result in a one-off pretax profit of £85 million after adjustments. Adds proceeds will support financial flexibility following recent refinancing and debt repayment activity.

----------

Nativo Resources PLC, up 37% at 0.43 pence, 12-month range 0.20p-0.90p. Notes contained gold of between around 6,686 and 195,434 ounces at its Tesoro gold project. The company also cites tonnages between 75,051 and 316,200 tonnes and superficial vein lengths of 6,200 metres within the concession.

----------

CelLBxHealth PLC, up 20% at 1.23 pence, 12-month range 0.85p-2.70p. Says it expects 2026 revenue of at least £2.1 million, up 50% from 2025, as the company progresses its turnaround strategy and builds its sales pipeline. The Guildford, England-based liquid biopsy company, formerly called Angle PLC says first-quarter trading focused on organisational restructuring and cost reductions. Following a 60% headcount reduction last year, staff numbers were further reduced to 39 from 44 in the first quarter. CelLBxHealth says these measures are expected to reduce annual cash operating costs in 2026 by more than £6.6 million, with a further £0.1 million of savings targeted in the second quarter. Cash at March 31 stood at £4.3 million, in line with expectations and reflecting one-off restructuring costs. The company says it has appointed a new US head of sales and remains focused on commercial execution. It adds that it is in advanced talks with a major private US healthcare provider regarding two clinical studies using its Parsortix platform, and is close to signing a master services agreement with a top-10 global pharmaceutical company.

----------

Shoe Zone PLC, down 5.6% at 42.50 pence, 12-month range 35.00p-120.00p. Reports wider interim loss and lower revenue as it warns on full-year performance. The footwear retailer says pretax loss in the first half widens to £5.3 million from £2.3 million a year prior, while revenue falls 12% to £62.9 million from £71.5 million. Adds it expects a full-year adjusted pretax loss of between £1.0 million and £2.0 million and proposes no interim dividend, unchanged from a year ago.

----------

Copyright 2026 Alliance News Ltd. All Rights Reserved.